Erol, C. Et Al. 2022. An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis. Journal of cancer research and therapeutics , vol.18, no.6 , 1809-1810.

Erol, C., Nahit Sendur, M. A., & YALÇIN, B., (2022). An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis. Journal of cancer research and therapeutics , vol.18, no.6, 1809-1810.

Erol, CİHAN, Mehmet Ali Nahit Sendur, And BÜLENT YALÇIN. "An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis," Journal of cancer research and therapeutics , vol.18, no.6, 1809-1810, 2022

Erol, CİHAN Et Al. "An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis." Journal of cancer research and therapeutics , vol.18, no.6, pp.1809-1810, 2022

Erol, C. Nahit Sendur, M. A. And YALÇIN, B. (2022) . "An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis." Journal of cancer research and therapeutics , vol.18, no.6, pp.1809-1810.

@article{article, author={CİHAN EROL Et Al. }, title={An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis}, journal={Journal of cancer research and therapeutics}, year=2022, pages={1809-1810} }